3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Lymphoid
1
Conditions
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
1
Lymphoma, Follicular
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Disease
1
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
1
Breast Neoplasms
1
Interventions
Cisplatin
72
Brachytherapy
31
Radiotherapy
26
Paclitaxel
23
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
21
human papillomavirus vaccine, L1 type 16, 18
20
Topotecan
18
Papillomavirus Vaccines
18
Carboplatin
18
Surveys and Questionnaires
17
Bevacizumab
16
pembrolizumab
14
Radiation
12
Gemcitabine
12
Early Intervention, Educational
12
Colposcopy
12
Methods
11
Magnetic Resonance Spectroscopy
11
atezolizumab
10
Radiotherapy, Intensity-Modulated
10
Blood Specimen Collection
10
Papanicolaou Test
9
Docetaxel
9
Vaccines, Synthetic
8
Platinum
8
Nivolumab
8
Ipilimumab
8
Counseling
8
1,2-diaminocyclohexaneplatinum II citrate
8
Vaccines
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Uterine Cervical Neoplasms
×
Diffusion Magnetic Resonance Imaging
×
Clear all
NCT01836484
2020-02-13
MAPPING
Barts & The London NHS Trust
Completed
162 enrolled
NCT01060033
2017-04-14
MRI
Washington University School of Medicine
Phase NA
Completed
9 enrolled